A sweeping genetic analysis suggests that the activity of certain genes might someday allow doctors to predict which lung cancer patients need more aggressive therapies and which do not. But the findings also underscore the difficulty of making such predictions, especially in the case of people with the earliest forms of the disease, when aggressive therapies could be of greatest value.

Full story: medicinenet.com